Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Neuroprotection, Cognitive Function, and Mental Focus With Neurodegradation Countermeasure

NCT05715073 is registered in ClinicalTrials.gov with University of South Carolina as lead sponsor.

NCT NCT05715073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05715073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Neuroprotection, Cognitive Function, and Mental Focus With Neurodegradation Countermeasure
Lead sponsor
University of South Carolina
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2023
Completion date
November 1, 2023
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine, cognitive change, hemodynamics, teacrine